Cann Global need to provide shareholders with additional information on what they will make on the sale of Canntab, if they want new investor to buy in. We have pharmacy's, hospital and CMOS, how long is this batch going to last before repurchasing more Canntab, we have the rights for Asia, who and how are we going to market that. Remembering 50/50, all sales is a 50/50. It still needs to be sold.
Ann: Export Permit Granted for Patented Canntab Hard Pill, page-19
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)